PATENT CLAIM ANALYSIS

Application Number: 16079802
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "330000"]

Abstract:
Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.

Claim (Index 9):
The method of  claim 8 , wherein the malignancy is acute myelogenous leukemia (AML), characterized by the presence of a mutant allele of IDH1.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15368405', '15767822', '15368439', '15768462', '15125880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8394462281731416
- 35 USC 102 Novelty (BERT): 0.5586565277775084
- Combined Prediction Score: 0.8113672581335782
- Mean Citation Score: 462.025804
- Max Citation Score: 504.7606
- Similarity Product: 398.03569004882576

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test